AI ScreeningAI ChatPricing
  1. US-listed companies
  2. FILANA THERAPEUTICS, INC.
  3. Raw

FILANA THERAPEUTICS, INC.【FLNA】

Market cap
$106.76M
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Research and Development Expense88579983----8970
General and administrative77555644348121772
Total operating expenses151510121415127563380106141
Operating loss-4-431-12-14-15-12-7-5-6-33-80-106-141
Interest income------------89
Other income, net----------0110
gain from change in fair value of warrant liabilities, liability--------------108
Net loss-3-332-12-14-15-12-7-5-6-32-76-97-24
Net loss per share, basic (in dollars per share)--0.7-0.27-0.31--------2.32-0.53
Net loss-3-332-12-14-15-12-7-5-6-32-76-97-24
Adjustment for change in fair value of warrant liabilities-------------44
Adjusted numerator, diluted--------------68
Net loss per share, diluted (in dollars per share)--0.7-0.27-0.31--------2.32-1.46